NCT00069849View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

July 31, 2003

Conditions

Alzheimer's Disease

Interventions

DRUG

ABT-089

Trial Locations (8)

Unknown

Fresno

San Diego

Orlando

West Palm Beach

Florence

Portland

Salt Lake City

Bennington

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY